array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(91) "Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS | BioSpace" ["snippet_en"]=> string(206) "Seeking a potential slice of the challenging KRAS market, Merck has launched a Phase III trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb." ["url"]=> string(113) "https://www.biospace.com/article/merck-launches-phase-iii-study-for-kras-hopeful-eyes-challenge-to-amgen-and-bms/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4b937899-1b0f-42a9-a60d-25584b0ef4ce" ["source"]=> string(12) "biospace.com" ["publication_date"]=> string(10) "2024-04-05" ["categories"]=> array(3) { [0]=> string(10) "New Market" [1]=> string(11) "Competition" [2]=> string(14) "Product Launch" } } [1]=> array(7) { ["title_en"]=> string(106) "LG Ensol and Qualcomm develop advanced BMS solution... improve computing performance by more than 80 times" ["snippet_en"]=> string(143) "[Hans Economy = Reporter Kwon Seon-hyung] LG Energy Solutions and Qualcomm Technologies Inc. have developed an advanced BMS (Battery Management" ["url"]=> string(62) "http://www.hansbiz.co.kr/news/articleViewAmp.html?idxno=683667" ["image_url"]=> NULL ["source"]=> string(13) "hansbiz.co.kr" ["publication_date"]=> string(10) "2024-03-11" ["categories"]=> array(2) { [0]=> string(17) "Energy Management" [1]=> string(14) "Product Launch" } } [2]=> array(7) { ["title_en"]=> string(63) "LG Energy Solution develops advanced BMS solution with Qualcomm" ["snippet_en"]=> string(576) "LG Energy Solutions and Qualcomm Technologies Inc. (Qualcomm Technologies Inc.) has joined hands to develop an advanced BMS (Battery Management System) diagnostic solution. LG Energy Solutions announced on the 10th that it will cooperate with Qualcomm to develop an advanced BMS diagnostic solution to be installed in next-generation electric vehicles. Through the partnership, the company plans to develop a more advanced, cutting-edge BMS solution by combining specific functions of LG Energy Solutions' BMS diagnostic software and Qualcomm's Snapdragon® Digital ChassisTM." ["url"]=> string(62) "http://www.koreaittimes.com/news/articleView.html?idxno=129577" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f1e7780b-8bc4-4480-8799-611d18af0d55" ["source"]=> string(16) "koreaittimes.com" ["publication_date"]=> string(10) "2024-03-01" ["categories"]=> array(4) { [0]=> string(17) "Energy Management" [1]=> string(14) "Product Launch" [2]=> string(6) "Energy" [3]=> string(13) "Collaboration" } } [3]=> array(7) { ["title_en"]=> string(68) "iBattMan project will create a smart battery management BMS platform" ["snippet_en"]=> string(163) "Within the framework of the new iBattMan project (Intelligent, connected and secure battery management system enhanced by NextGeneration Edge and Cloud Computing)," ["url"]=> string(109) "https://www.smartgridsinfo.es/2024/01/15/proyecto-ibattman-creara-plataforma-bms-gestion-baterias-inteligente" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a5159174-86c0-4beb-94ce-53d4a4ccd12b" ["source"]=> string(17) "smartgridsinfo.es" ["publication_date"]=> string(10) "2024-01-15" ["categories"]=> array(6) { [0]=> string(5) "R & D" [1]=> string(37) "Product Design & Lifecycle Management" [2]=> string(14) "Product Launch" [3]=> string(13) "Collaboration" [4]=> string(20) "Business Development" [5]=> string(13) "Data Security" } } [4]=> array(7) { ["title_en"]=> string(40) "New Teleco TLI Premium lithium batteries" ["snippet_en"]=> string(116) "Teleco launches TLI lithium batteries with built-in BMS technology and a container for 104, 120 and 150Ah batteries." ["url"]=> string(85) "https://www.autocaravanas.es/nuevas-baterias-de-litio-teleco-tli-premium-2023-546127/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/45cd4426-c684-43f5-ac9d-8551fd69b074" ["source"]=> string(16) "autocaravanas.es" ["publication_date"]=> string(10) "2023-11-22" ["categories"]=> array(2) { [0]=> string(37) "Product Design & Lifecycle Management" [1]=> string(14) "Product Launch" } } [5]=> array(7) { ["title_en"]=> string(60) "BMS launches its M&A division in Spain by signing Linklaters" ["snippet_en"]=> string(70) "The broker BMS Group has hired Ricardo Lecaro for the launch of its..." ["url"]=> string(99) "https://www.grupoaseguranza.com/noticias-de-seguros/bms-lanza-division-m-espana-fichando-linklaters" ["image_url"]=> NULL ["source"]=> string(19) "grupoaseguranza.com" ["publication_date"]=> string(10) "2023-11-13" ["categories"]=> array(4) { [0]=> string(6) "Merger" [1]=> string(11) "Acquisition" [2]=> string(14) "Product Launch" [3]=> string(10) "New Market" } } [6]=> array(7) { ["title_en"]=> string(54) "New generation of electric feed mixers from Strautmann" ["snippet_en"]=> string(220) "At this year's Agritechnica, the Strautmann company is presenting a completely new series of machines. The Strautmann eVerti feed. This is a fully battery-electric feed mixer with a power car and integrated driver's cab." ["url"]=> string(95) "https://www.ufarevue.ch/newsticker/neue-generation-elektrischer-futtermischwagen-von-strautmann" ["image_url"]=> string(78) "https://images.businessradar.com/articles/13b399a8-57e8-4dc8-a5c6-5aea3b371234" ["source"]=> string(11) "ufarevue.ch" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(8) { [0]=> string(5) "R & D" [1]=> string(17) "Electric Vehicles" [2]=> string(37) "Product Design & Lifecycle Management" [3]=> string(18) "Expansion & Growth" [4]=> string(14) "Product Launch" [5]=> string(17) "Energy Management" [6]=> string(19) "Green & Responsible" [7]=> string(13) "GHG Emissions" } } [7]=> array(7) { ["title_en"]=> string(58) "University of Alcalá, Clover and BMS launch a new diploma" ["snippet_en"]=> string(114) "This second edition aims to acquire advanced training aimed at specialization within the area of ​​Immunology." ["url"]=> string(119) "https://www.consalud.es/profesionales/universidad-alcala-clover-bms-diploma-experto-bases-inmunologicas_135228_102.html" ["image_url"]=> NULL ["source"]=> string(11) "consalud.es" ["publication_date"]=> string(10) "2023-10-03" ["categories"]=> array(4) { [0]=> string(5) "R & D" [1]=> string(11) "Acquisition" [2]=> string(17) "Academic Research" [3]=> string(14) "Product Launch" } } [8]=> array(7) { ["title_en"]=> string(160) "Cell Theraputics Market Revenue and Size Outlook | Companies Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics - Glasgow West End Today" ["snippet_en"]=> string(99) "Press Release - (Orbisresearch.com) - The key vendors' strengths and weaknesses are assessed in the" ["url"]=> string(158) "https://glasgowwestend.today/cell-theraputics-market-revenue-and-size-outlook-companies-bristol-myers-squibb-company-celgene-bluebird-bio-crispr-therapeutics/" ["image_url"]=> NULL ["source"]=> string(20) "glasgowwestend.today" ["publication_date"]=> string(10) "2023-07-26" ["categories"]=> array(1) { [0]=> string(14) "Product Launch" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company

Bristol-Myers Squibb Company

Location

New York

Founded

1887-02-28

Website

https://www.bms.com

Articles

2495 Articles

Category

Pharmaceutical Preparations

Description

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Articles

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS | BioSpace

2024-04-05 (biospace.com)

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS | BioSpace

Seeking a potential slice of the challenging KRAS market, Merck has launched a Phase III trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb.

Read more
LG Ensol and Qualcomm develop advanced BMS solution... improve computing performance by more than 80 times

2024-03-11 (hansbiz.co.kr)

LG Ensol and Qualcomm develop advanced BMS solution... improve computing performance by more than 80 times

[Hans Economy = Reporter Kwon Seon-hyung] LG Energy Solutions and Qualcomm Technologies Inc. have developed an advanced BMS (Battery Management

Read more
LG Energy Solution develops advanced BMS solution with Qualcomm

2024-03-01 (koreaittimes.com)

LG Energy Solution develops advanced BMS solution with Qualcomm

LG Energy Solutions and Qualcomm Technologies Inc. (Qualcomm Technologies Inc.) has joined hands to develop an advanced BMS (Battery Management System) diagnostic solution. LG Energy Solutions announced on the 10th that it will cooperate with Qualcomm to develop an advanced BMS diagnostic solution to be installed in next-generation electric vehicles. Through the partnership, the company plans to develop a more advanced, cutting-edge BMS solution by combining specific functions of LG Energy Solutions' BMS diagnostic software and Qualcomm's Snapdragon® Digital ChassisTM.

Read more
iBattMan project will create a smart battery management BMS platform

2024-01-15 (smartgridsinfo.es)

iBattMan project will create a smart battery management BMS platform

Within the framework of the new iBattMan project (Intelligent, connected and secure battery management system enhanced by NextGeneration Edge and Cloud Computing),

Read more
New Teleco TLI Premium lithium batteries

2023-11-22 (autocaravanas.es)

New Teleco TLI Premium lithium batteries

Teleco launches TLI lithium batteries with built-in BMS technology and a container for 104, 120 and 150Ah batteries.

Read more
BMS launches its M&A division in Spain by signing Linklaters

2023-11-13 (grupoaseguranza.com)

BMS launches its M&A division in Spain by signing Linklaters

The broker BMS Group has hired Ricardo Lecaro for the launch of its...

Read more
New generation of electric feed mixers from Strautmann

2023-11-10 (ufarevue.ch)

New generation of electric feed mixers from Strautmann

At this year's Agritechnica, the Strautmann company is presenting a completely new series of machines. The Strautmann eVerti feed. This is a fully battery-electric feed mixer with a power car and integrated driver's cab.

Read more
University of Alcalá, Clover and BMS launch a new diploma

2023-10-03 (consalud.es)

University of Alcalá, Clover and BMS launch a new diploma

This second edition aims to acquire advanced training aimed at specialization within the area of ​​Immunology.

Read more
Cell Theraputics  Market Revenue and Size Outlook | Companies Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics - Glasgow West End Today

2023-07-26 (glasgowwestend.today)

Cell Theraputics Market Revenue and Size Outlook | Companies Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics - Glasgow West End Today

Press Release - (Orbisresearch.com) - The key vendors' strengths and weaknesses are assessed in the

Read more

Newsletter subscription